|
Specificity
|
By Immunoblotting and ELISA the antibody shows approximately 5% cross-reactivity with recombinant human MIP3 beta. In addition, the antibody shows no crossreactivity with other chemokines tested: rh6Ckine, rm6Ckine, rhBLC/BCA 1, rmC10, rrCINC1, rrCINC2 alpha, rrCINC2 beta, rmCRG2, rhENA78, rhEotaxin, rmEotaxin, rhEotaxin 2, rhFractalkine, rmFractalkine, rhGCP2, rmGCP2, rhGRO alpha, rhGRO beta, rhGRO gamma, rhHCC-1, rhI309, rhHCC4, rhIL8, rhIP10, rhI-TAC, rmJE, rhLeukotactin-1, rmLymphotactin, rmMARC, rhMCP1, rhMCP2, rhMCP3, rhMCP4, rmMCP5, rhMDC, rmMDC, rhMIG, rmMIG, rvMIPI, rhMIP1 alpha, rmMIP1 alpha, rhMIP1 beta (ACT II), rvMIPII, rvMIPIII, rmMIP1 beta, rhMIP1 delta, rmMIP1 gamma, rmMIP2, rhMIP3 alpha, rrMIP3 alpha, rhMIP3 beta, rmMIP3 beta, rhMPIF1, rhNAP2, rhPARC, rhRANTES, rmRANTES, rhSDF1 alpha, rmSDF1 alpha, rhSDF1 beta, rhTarc, rmTCA3, rhTeck, rmTeck.
|